Abbott Laboratories (ABT)
Why Abbott (ABT) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Hope for the Best and Plan for the Worst: The 5 Safest Dividend Aristocrats
The stock market could face serious trouble in 2026 as extreme valuations collide with geopolitical tensions, AI investment skepticism, and policy headwinds.
Abbott (ABT) is a Top-Ranked Growth Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Abbott (ABT) Rises Higher Than Market: Key Facts
Abbott (ABT) reached $112.65 at the closing of the latest trading day, reflecting a +2.82% change compared to its last close.
Abbott Laboratories Offers Long-Term Upside Despite Recent Stumbles
Abbott Laboratories (ABT) remains a Buy, with the stock undervalued at $109.56 despite recent execution missteps and Nutrition segment weakness. Core Devices and Diagnostics segments continue to deliver high single-digit sales growth and double-digit EPS growth, supporting the investment thesis. Nutrition remains a key risk, but management expects a turnaround in the second half; Exact Sciences acquisition could add a new high-growth vertical.
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
Abbott (ABT) Stock Sinks As Market Gains: Here's Why
Abbott (ABT) closed at $114.12 in the latest trading session, marking a -1.92% move from the prior day.
Abbott (ABT) Ascends While Market Falls: Some Facts to Note
Abbott (ABT) reached $115.29 at the closing of the latest trading day, reflecting a +2.74% change compared to its last close.
Abbott (ABT) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Abbott (ABT) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Alliance Wealth Advisors LLC UT Has $2.44 Million Position in Abbott Laboratories $ABT
Alliance Wealth Advisors LLC UT lowered its stake in Abbott Laboratories (NYSE: ABT) by 30.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 18,225 shares of the healthcare product maker's stock after selling 8,086 shares during the quarter. Alliance
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
